GB2520907B - A system for determining and applying treatment parameters for an electrical interferential treatment regime - Google Patents

Description

A system for determining and applying treatment parameters for an electrical intetferential treatment rsalme

This application is based on PCT Application S.N. PCT/2013/000211, filed September 13, 2013, priority of which is claimed.

This invention relates to a system for determining and applying treatment parameters for an electrical interferential treatment regime.

Background of the Invention U.S. Patent Application 11/374,903, filed March 14, 2006, Publication No. US 2009/0219598, now U.S. Patent 8,515,551, the disclosure of which is incorporated herein by reference, discloses a technique for determining better parameters for an electrical interferential treatment by delivering various pulses and electrode locations and measuring the patient’s response to the applied treatment. By varying these parameters and exercising experienced judgment, an effective set of parameters is obtained for treating the ailment presented by the patient.

Disclosures of some interest relative to this invention are found in U.S. Patents 4,505,275; 6,016,447; 6,154,675; 6,698,921 and U.S. Printed Patent Applications 20020003832; 20070150029; 20100063564; 20100106226; 20100211135; 20100222844; 20110105916; 20110106216; 20110152974; 20110231836 and 20110313488.

Summary of the Invention

According to the present invention there is provided a system for determining and applying treatment parameters for an electrical interferential treatment regimen conducted on a patient situated at a first location remote from a second location, comprising:

Pairs of electrodes adapted for external temporary attachment, respectively, to opposite limbs of a patient situated at said first location and at least one data processor at said first location for delivering a series of electrical interferential treatments to the patient through the electrodes, and each electrical interferential treatment comprises a series of different beat frequencies a digit temperature sensor sensing autonomic nervous system activity of the patient in response to each electrical interferential treatment parameter delivered; said at least one data processor responsive to said sensor and adapted to provide an outputs indicative of the response, said outputs being a change of digit temperature; said at least one data processor further adapted to store data of said outputs of said treatment parameters of said series of electrical interferential treatments; said at least one data processor further adapted to electronically transmit said stored data of said outputs to at least one other data processor situated at a second location remote from the first location; a communication link communicating with the data processor for transmitting data from the data processor so it can be determined from the second location whether the selected parameters obtained from the first location constitute a preferred treatment regimen in which the patient's temperature is raised above a predetermined threshold said at least one data processor further adapted to allow selection of said treatment parameters from one of the test treatments prior to electrical interferential treatments being applied through the electrodes to the patient in a subsequent selected treatment regimen; and said at least one data processor and said at least one other data processor are adapted for viewing said outputs of, said treatment parameters of said series of electrical interferential treatments and determining from said stored data whether said treatment parameters of said identified electrical interferential treatment produced an output of said change of digit temperature above a predetermined threshold.

In an attempt to obtain more efficient treatment parameters, shorten the time to determine these parameters, require less experienced personnel and rely on patients or their caregivers to determine effective parameters, the responses of the patient may be entered into software designed to obtain better parameters. The software may contain a series of logic circuits which may be briefly described as an effort to determine whether the patient experiences improved blood flow in response to the application of a series of treatment parameters.

One broad manner of intended use of the disclosed technique is for the patient to be initially treated by professionals in a professional setting where a first set of treatment parameters is obtained and a first treatment delivered to the patient. Many subsequent treatments may be conducted by the patient or caregiver at a location other than a professional office, such as at the patient's residence. In order to run subsequent treatments, a new set of treatment parameters may preferably be obtained by the device using the same device and software.

The hardware and software obtain, in an automated way, the patient's response to a senes of treatment parameters and saves or stores the patient’s responses to the parameters, typically on an electronic storage medium, along with the parameters, the time and manner the parameters were determined and other pertinent information. Similarly, the time and parameters used in a treatment may also be saved or stored. A communications link is provided to allow a professional to check on whether the treatment parameters were selected in an appropriate manner. Similarly, the communications link may be used to allow a professional to check on whether the treatments were in fact done and done in a manner and at a time consistent with best practice.

Brief Description of the Drawings

Figure 1 is a flow chart of an automated parameter selection technique;

Figure 2 is a combined schematic view of a diagnostic system and a pictorial view of the application of electrodes to a patient in accordance;

Figure 3 is a view of a finger tip temperature sensor;

Figure 4 is a schematic view of one embodiment of a communications link; and

Figure 5 is a schematic view of another embodiment of the disclosed technique.

Detailed Description of the invention

In the practice of the disclosed technique, electrical energy in the form of electrical interferential pulses are delivered into the patient's body. These treatments cause change in the patient which is monitored by the disclosed device. In other words, the effect of the electrical interferential pulses is monitored by one or more sensors that detect a function or an aspect of the autonomic nervous system. The sensed changes in the patient are then used to modify the output of the treatment unit and/or the placement of the electrodes used by the treatment machine. In other words, the results of the tests are used in an attempt to determine a preferred way to treat the patient by adjusting the treatment machine in response to the tests results. A healthy organism is capable of quickly adjusting to many external influences because of an adequate sympathetic response. Once that factor disappears, parasympathetic activity increases, which balances overall autonomic activity. It has become known that a large majority of people have overly active sympathetic nervous systems, i.e. their sympathetic nervous systems are overpowering or dominating their parasympathetic nervous system. This may have many effects, some of which may be controversial although many are not. In general, an overly active sympathetic nervous system tends to create or accentuate such diverse conditions or ailments such as diabetes type 1 and type 2, fibromyalgia, bipolar disorder, endometriosis, hypertension and other ailments such as disclosed in Application S.N. 11/326,230, filed January 5, 2006 orthose ailments disclosed in U.S. Patent 5,995,873. A wide variety of techniques may be used to monitor the autonomic nervous system and thereby determine the effect of an interferential treatment on the patient. A preferred technique is to monitor finger tip temperature because the response is relatively rapid, easy to measure and is relatively unambiguous.

Referring to Figures 1-2, a patient 10 is hooked up to an electrical interferential therapy device 12 inside a housing 14. The electrical interferential therapy device 12 may include a more-or-less conventional treatment module 16 such as is commercially available from Dynatronics Inc. (RTM) of Salt Lake City, Utah, to which reference is made for a more complete description thereof and as explained more fully hereinafter. The reaction of the patient 10 is monitored by one or more sensors 18, 20 which comprise a digital temperature sensor incorporated into a spring biased clip which may attach to a finger or toe on each side of the patient. Each sensor 18, 20 may be connected by a wire 22, 24 to a module 28 in the housing 14. The module 28 is a data processor to record the temperature sensings from the sensors 18, 20, store the values in a memory module 30, control the treatment module 16 and otherwise operate the device 12. In some embodiments, the memory module 30 may be removable from the housing 14 for purposes more fully explained hereinafter.

The housing 14 may include a pair of receptacles 32, 34 capable of accepting a jack 36, 38 of insulated wire pairs 40, 42 leading to electrode pairs 44, 44’ and 46, 46'. A suitable display 48 provides readings such as values from the sensors 18, 20, the carrier frequency, the pulse frequency being tested, the time and date of the procedure and any other desirable information, such as the intensity of treatment, time left to finish the treatment, time elapsed during a particular testing cycle, results of testing sequences, and whether it is time to replace the electrodes.

Standard commercially available electrical interference treatment devices have either a fixed carrier frequency or a minimally selective carrier frequency. For reasons which are mainly historical, these frequencies are conventionally 1850 Hz and 2850 Hz in the Sympathetic Therapy System from Dynatronics, Inc. (RTM) and 4000 Hz in a device commercially available by Rehabiiicare Corporation (RTM) of St. Paul, Minnesota. In this device, the carrier frequency may be either fixed or variable.

The device 12 may include a select actuator 50 and up/down actuators 52, 54. It is sometimes desirable to increase the intensity of the electrical puises. Assuming the actuator 52 to increase intensity, it may be manually depressed and an intensity value may be displayed on the screen 48. When the desired intensity value shows on the screen 48, the select actuator 50 may be depressed to instruct the module 28 to increase the intensity to the selected value. The module 28 may provide other functions. For example, the electrodes 44, 44', 46, 46' don't provide good sensings indefinitely. The module 28 may run tests to determine whether the electrodes need to be replaced, may count the number of treatments or the number of parameter determining trials are run and display a message on the screen 48 to replace the electrodes. In response to such a message, the select actuator 50 may be depressed to send a message to the module 28 that the electrodes have been or will be changed. The device 12 may also include a timer function and the time of and duration of treatments and/or the acquisition of treatment parameters. The device 12 may also include an on-off switch 56.

The carrier and beat frequencies used in selecting treatment parameters may be selected by the actuators 50, 52, 54 or default selections may be provided by software in the processor 28. Experience has shown that the vast majority of desirable beat frequencies are between 1-150 beats per second (bps) although current commercially available devices only employ 1-80 beats per second. In attempts to find the most desirable beat frequency in a reasonable time frame, this range has been subdivided into smaller segments. Experience has shown that some of the segments, at least at one carrier frequency where most efforts have been made, provide the most desirable beat frequency.

When it is desired to increase the treatment intensity, the increase actuator 52 is depressed. When it is desired to decrease the treatment intensity, the decrease actuator 54 is depressed. It will accordingly be seen that the device 12 includes a circuit for delivering therapeutic electrical energy into the body of the patient and more particularly includes a subcircuit for modifying the carrier frequency, the beat frequency and/or the amplitude of alternating current type energy.

The first thing that may be done is to allow or insure that the finger tip temperature of the patient has stabilized. The patient's finger temperatures often change in response to room temperature and it may be desirable to allow them to cease responding to room temperature. This may be done by measuring the initial temperature of the patient's finger tips and determining whether the temperature is varying over time. At the end of a short specified period, e.g. one minute, a determination is made whether finger tip temperature has stabilized by comparing initial and subsequent temperatures. A suitable set of parameters is that when finger tip temperature changes less than 1°F (0.56°C) in one minute, the processor 28 determines that temperature has stabilized and the acquisition of treatment parameters continues in accordance with Figure 1.

The electrodes are attached to the patient's skin in a conventional manner, i.e. they may be seif adherent. The location of the electrodes on the patient establish the electrical circuit in the patient's body. As shown in Figure I, in one technique, one electrode 44 is placed adjacent the end or terminus of the right medial plantar nerve L5 and its matching electrode or mate 44' is placed adjacent the end or terminus of the left surai nerve S1, inferior to the left ankle bone (lateral malleolus) thereby establishing or creating a first circuit 58 in the patient's body. As used herein, the reference characters L5, S 1 and the like are standard medical terminology for the nerve. Those skilled in the art will recognize L5 as being the nerve which extends away from the fifth lumbar vertebra and 81 as being the nerve which extends away from the first sacral vertebra.

The electrode pattern illustrated in Figure 2 and as described is shown in U.S. Patent 5,995,873. In addition to the L5-S1 pattern described above, a preferred approach may be to employ an additional four electrodes for a total of eight electrodes. The additional electrodes may be placed in any suitable manner, such as in a L4-S2, L5-L4 pattern or in acupuncture sites on the feet.

Those skilled in the art will recognize that the terminus of the right medial plantar nerve L5 is located on the bottom of the right foot, approximately on the ball of the foot. The terminus of the left sural nerve S1 is located below the left ankle bone (lateral malleolus). Another electrode 46 is placed adjacent the terminus of the right sural nerve S1 and its matching electrode or mate 46’ is placed adjacent the terminus of the left medial plantar nerve L5 thereby establishing a second circuit 60 in the patient's body. Turning the device 12 on delivers electrical energy through the circuits 58, 60. Those skilled in the art will recognize that the medial plantar nerves L5 and the sural nerves S1 terminate adjacent the spinal column near adjacent spinal vertebra, in the area of the connection to the lumbar sympathetic ganglia.

Other arrangements of the electrodes to stimulate other nerves are within the scope of this invention and are shown in U.S. Patent 5,995,873. It is desirable to start the acquisition of treatment parameters by selecting one arrangement that experience has shown to often produce effective treatments.

Referring to Figure 3, there is illustrated a suitable temperature sensor 18 of a type available from Minnesota Wire Company (RTM) of Saint Paul, Minnesota. The sensor 18 may include a pair of clip sections 62, 64 connected for pivotal movement about an axis 66. A spring (not shown) biases the sections 62, 64 together. An infrared temperature sensor (not shown) or other suitable temperature measuring device is incorporated into one or the other of the clip sections 62, 64. In the alternative, an infrared sensor (not shown) may be exposed on the housing 14 so the patient simply places fingertips on the housing 14.

Initially, the patient is briefly subjected to no carrier frequency or frequencies or beat frequency or frequencies for a short period, typically about five minutes, in order to allow the thermistors to equilibrate to the finger temperature. Then, the patient is subjected to a series of tests, initially using different beat frequencies in an attempt to determine an effective, optimum or ideal combination of parameters that produce a desired effect on the autonomic nervous system and thereby determine a preferred treatment regimen. This may be accomplished by using one of the carrier frequencies and delivering a series of pulses in a first range, such as 1-10 pulses/second, while sensing and recording the temperature measured by the sensors 18, 20. The sequence of delivering the pulses may be in any suitable manner. The standard interferential module 16 produces a sweep of beats in this range in the following repeating pattern: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1, changing every second. The finger tip temperature may be recorded continuously or at any suitable interval, e.g. one minute. A hypothetical temperature pattern conducted on a female having an original left finger tip temperature of 71,2°F (21,78°C) and an original right finger tip temperature of 72.6°F (22.56°C) is shown in Table I:

Table I left right finger finger average initial 71.2 F (21.78°C) 72.6 F (22.56°C) 71.9 (22.17°C) endofl min 71.6 (22°C) 72.8 F (22.67°C) 72.2 (22.33°C) end Of 2 min 71.6(22°C) 72.8 F (22.67°C) 72.2 (22.33°C) end of 3 min 71.6 (22°C) 72.6 F (22.56°C) 72.1 (22.28°C)

The purpose of the trial is to determine parameters that produce a significant increase in digit temperature based on the premise that this is a proxy for improved blood circulation. Table I shows a situation where the subject's finger tip temperature increased about 0.4 °F (0.22°C) in three minutes. This suggests a minimal increase in blood circulation so software in the processor module 28 concludes the selected pulse beat frequency and electrode placement is ineffective.

The module 28 accordingly writes onto the memory module 30 information relevant to the trial, e.g. the serial number of the device 12, the time and date of the trial, and all of the data created during the testing and running of the treatment onto the memory module 30.

If the temperature response from the first trial is not satisfactory, as in Table I, which may be where the digit temperature increase is less than 1°F (0.56°C), then a second trial may commence using a different pulse frequency, e.g. 11-20 beats per second. This process repeats until a temperature increase above some minimum, which is preferably at least 1°F (0.56°C) in a few minutes such as three or four minutes, is attained or until some maximum range is reached. If there is no successful trial after trying each ten pulse range through the maximum range, a message appears on the display 48 to try a different electrode pattern and/or a different carrier frequency. The process is repeated until a satisfactory temperature increase is obtained. All of the trial parameters and trial results are written onto the memory module 30.

Following a successful trial that determines parameters suggesting substantially improved blood flow, i.e. the temperature response is above a predetermined threshold such as a 1°F (0.56aC) temperature rise in a fewminutes, the selected treatment may be delivered to the patient in response to a message on the display 48 or automatically. The patient, caregiver or professional may instruct the device 12 to apply the treatment by depressing the select actuator 50. If, having tested all of the beat frequency permutations available, no combination is able to create an adequate thermistor temperature increase indicating an adequate circulation increase, the beat frequency combination which created the highest increase will be utilized for the treatment. At the end of the treatment, a message appears on the display 48 saying “new protocol needed" or other similar message advising the clinician or patient that a different electrode placement is needed. In the alternative, in a situation where the patient or caregiver is conducting these trials at a location remote from the professional’s premises, the message may indicate that the professional be contacted to determine another electrode pattern or that a reference book or data base be used to determine another electrode pattern.

The memory module 30 provides an important advantage. There are situations where the patient or patient's caregiver is conducting trials to determine suitable parameters and then delivering treatments at a location away from the professional's office, e.g. at the patient's residence. In this situation, it is very desirable to have the capability of reviewing the trial procedures and results. In the case of a removable memory module, the module 30 may be removed and placed in a computer 68 where data from the module 30 is transmitted through a communication link 70 to the professional’s office 72 where the data can be stored on a computer 74, retrieved and viewed (Figure 4). In this manner, the professional can determine from a location remote from the patient whether the parameter determining trials were run and run correctly. Manifestly, if the parameter determining trials are run incorrectly or not run at all, this can be determined by the professional and appropriate steps taken to correctly determine parameters. It is difficult to overstate the importance of this advantage. It will be apparent that the communications link 64 may be of any suitable type, such as by an Internet connection.

The communication link 70 also allows the professional to review whether, when and how treatments were conducted because treatment information, as well as parameter acquisition information, is written onto and stored on the memory module 30. Thus, treatment information as well as parameter information may be transmitted to the professional.

Referring to Figure 5, there is illustrated another embodiment of an interferential device 76 including an interferential treatment module 78 and a processor module 80 which includes all of the functions of the processor 28 and a communication module 82 providing a communication link 84 directly with a computer 86 in a professional's office 88. The communication link 84 may be of any suitable type, such as a cell phone, Internet connection or the like. It will be seen that the interferential device 76 transmits parameter determining information as well as treatment information to the computer 86 so it may be reviewed for accuracy and timeliness.

Claims (6)

13 Claims

1. A system for determining and applying treatment parameters for an electrical interferential treatment regimen conducted on a patient situated at a first location remote from a second location, comprising: pairs of electrodes adapted for external temporary attachment, respectively, to opposite limbs of a patient situated at said first location and at least one data processor at said first location for delivering a series of electrical interferential treatments to the patient through the electrodes, and each electrical interferential treatment comprises a series of different beat frequencies a digit temperature sensor sensing autonomic nervous system activity of the patient in response to each electrical interferential treatment parameter delivered; said at least one data processor responsive to said sensor and adapted to provide an outputs indicative of the response, said outputs being a change of digit temperature; said at least one data processor further adapted to store data of said outputs of said treatment parameters of said series of electrical interferential treatments; said at least one data processor further adapted to electronically transmit said stored data of said outputs to at least one other data processor situated at a second location remote from the first location; a communication link communicating with the data processor for transmitting data from the data processor so it can be determined from the second location whether the selected parameters obtained from the first location constitute a preferred treatment regimen in which the patient’s temperature is raised above a predetermined threshold 14 said at least one data processor further adapted to allow selection of said treatment parameters from one of the test treatments prior to electrical interferential treatments being applied through the electrodes to the patient in a subsequent selected treatment regimen; and said at least one data processor and said at least one other data processor are adapted for viewing said outputs of, said treatment parameters of said series of electrical interferential treatments and determining from said stored data whether said treatment parameters of said identified electrical interferential treatment produced an output of said change of digit temperature above a predetermined threshold.

2. A system according to claim 1. wherein the at least one data processor is further adapted to store the time and date of the application of each series of treatment parameters and the treatment parameters of the identified electrical interferential treatment.

3. A system according to claim 1 or 2, wherein the data processor is further adapted to determine whether the applied selected treatment parameters produce at least a one degree Fahrenheit (0.56 °C) increase in digit temperature in less than four minutes thereby constituting a preferred treatment regimen.

4. A system according to claim 1 or 2, wherein said digit temperature sensor is adapted to measure a patient's digit temperature prior to delivering the series of electrica! interferential treatments and, said at ieast one data processor, in response to a measured rate of change of digit temperature falling below- a predetermined value, is adapted to deliver said series of electrical interferential treatment parameters through the electrodes. 15

5. A system according to claim 4, wherein the predetermined value of the rate of change is at east one degree Fahrenheit (0.56 °C) per minute.

6. A system according to claim 1, wherein the first location comprises a residence of the patient and the second location comprises a professional office.